Jonathan P Mow is Chief Executive Officer of PhaseBio Pharmaceuticals Inc. Currently has a direct ownership of 132,502 shares of PHAS, which is worth approximately $0. The most recent transaction as insider was on May 20, 2022, when has been sold 10,918 shares (Common Stock) at a price of $0.68 per share, resulting in proceeds of $7,424. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 133K
0% 3M change
0% 12M change
Total Value Held $0

Jonathan P Mow Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2022
BUY
Grant, award, or other acquisition
$7,424 $0.68 p/Share
10,918 Added 7.61%
132,502 Common Stock
Nov 19 2021
BUY
Grant, award, or other acquisition
$11,302 $2.01 p/Share
5,623 Added 3.16%
172,473 Common Stock
Nov 03 2021
BUY
Exercise of conversion of derivative security
$24,800 $1.24 p/Share
20,000 Added 10.7%
166,850 Common Stock
Aug 27 2021
BUY
Exercise of conversion of derivative security
$24,800 $1.24 p/Share
20,000 Added 11.99%
146,850 Common Stock
May 20 2021
BUY
Grant, award, or other acquisition
$11,099 $2.8 p/Share
3,964 Added 3.03%
126,850 Common Stock
Nov 20 2020
BUY
Grant, award, or other acquisition
$10,929 $3.0 p/Share
3,643 Added 2.88%
122,886 Common Stock
JPM

Jonathan P Mow

Chief Executive Officer
Malvern, PA

Track Institutional and Insider Activities on PHAS

Follow PhaseBio Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAS shares.

Notify only if

Insider Trading

Get notified when an Phase Bio Pharmaceuticals Inc insider buys or sells PHAS shares.

Notify only if

News

Receive news related to PhaseBio Pharmaceuticals Inc

Track Activities on PHAS